Release Date: 07/03/12 19:21 Summary: AGL COMPLETES ALLOCATION OF SUBORDINATED NOTES Price Sensitive: Yes Download Document 46.65KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status